FY21 outlook

FY21 Outlook Update


In November 2020 Gentrack Group Limited (NZX/ASX: GTK) (“Gentrack”) advised that it expected that the full year EBITDA run rate for FY21 would be well below that of the H2 FY20 run rate and that FY21 profitability may be reduced closer to break-even depending on the levels of future product investment and other factors.


Gentrack now provides the following outlook update:
• FY21 revenues are expected to be close to or slightly ahead of FY20 revenues of $100.5m
• FY21 EBITDA is expected to be around $5m on the basis that research and development (R&D) costs are expensed
• Incremental R&D costs are expected to be ~$3m/quarter from Q3 FY21
• The company expects to be net cashflow positive in FY21, building on the $16.8m of net cash reported at 30th September 2020.

Profit and cashflow are expected to be weighted to H1 FY21 given the incremental R&D spend forecast for H2.
(All $ amounts referred to above are NZ$)
ENDS


Contact:
James Spence, CFO +64 9 966 6090


About

Latest News

Mar 30 2021

Issue of Performance Rights

Feb 25 2021

Annual Meeting – Video Link

Feb 24 2021

Annual Meeting Results

Feb 24 2021

Annual Meeting of Shareholders Presentation

Be the first to know

I consent to receive Gentrack News and Views*

Our Customers